-
Gregory Hamm (AstraZeneca). Project details The tumour immunity cycle involves cyclical trafficking of T cell subsets between the tumour and lymphoid organs. While current immunotherapy has focused on re
-
tumours and metastases with the goal to design combinatorial therapeutic approaches. The project will involve the use of genetically complex organoid-derived transplantation mouse models of pancreatic
-
comprehensive model of what tranquillity is, the factors that influence it and how to design for it. Attention to design contexts and design processes will be key to ensuring that useful measurements, methods and
Searches related to current modeling
Enter an email to receive alerts for current-modeling positions